Logo image of IMXI

INTERNATIONAL MONEY EXPRESS (IMXI) Stock Fundamental Analysis

NASDAQ:IMXI - US46005L1017 - Common Stock

14.55 USD
-0.02 (-0.14%)
Last: 9/5/2025, 10:34:37 AM
Fundamental Rating

6

Taking everything into account, IMXI scores 6 out of 10 in our fundamental rating. IMXI was compared to 102 industry peers in the Financial Services industry. IMXI has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. IMXI may be a bit undervalued, certainly considering the very reasonable score on growth These ratings could make IMXI a good candidate for value investing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year IMXI was profitable.
IMXI had a positive operating cash flow in the past year.
In the past 5 years IMXI has always been profitable.
IMXI had a positive operating cash flow in 4 of the past 5 years.
IMXI Yearly Net Income VS EBIT VS OCF VS FCFIMXI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

1.2 Ratios

Looking at the Return On Assets, with a value of 9.93%, IMXI belongs to the top of the industry, outperforming 89.22% of the companies in the same industry.
IMXI has a better Return On Equity (36.17%) than 95.10% of its industry peers.
IMXI has a better Return On Invested Capital (21.36%) than 95.10% of its industry peers.
IMXI had an Average Return On Invested Capital over the past 3 years of 20.03%. This is significantly above the industry average of 7.59%.
The last Return On Invested Capital (21.36%) for IMXI is above the 3 year average (20.03%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 9.93%
ROE 36.17%
ROIC 21.36%
ROA(3y)11.41%
ROA(5y)12.2%
ROE(3y)40.58%
ROE(5y)38.06%
ROIC(3y)20.03%
ROIC(5y)20.57%
IMXI Yearly ROA, ROE, ROICIMXI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30 40

1.3 Margins

Looking at the Profit Margin, with a value of 8.01%, IMXI is in line with its industry, outperforming 47.06% of the companies in the same industry.
IMXI's Profit Margin has improved in the last couple of years.
With a Operating Margin value of 14.32%, IMXI perfoms like the industry average, outperforming 52.94% of the companies in the same industry.
In the last couple of years the Operating Margin of IMXI has grown nicely.
Industry RankSector Rank
OM 14.32%
PM (TTM) 8.01%
GM N/A
OM growth 3Y0.47%
OM growth 5Y5.87%
PM growth 3Y-4.31%
PM growth 5Y7.81%
GM growth 3YN/A
GM growth 5YN/A
IMXI Yearly Profit, Operating, Gross MarginsIMXI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

7

2. Health

2.1 Basic Checks

IMXI has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, IMXI has less shares outstanding
IMXI has less shares outstanding than it did 5 years ago.
The debt/assets ratio for IMXI is higher compared to a year ago.
IMXI Yearly Shares OutstandingIMXI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
IMXI Yearly Total Debt VS Total AssetsIMXI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

An Altman-Z score of 3.58 indicates that IMXI is not in any danger for bankruptcy at the moment.
IMXI has a Altman-Z score of 3.58. This is amongst the best in the industry. IMXI outperforms 84.31% of its industry peers.
The Debt to FCF ratio of IMXI is 1.97, which is an excellent value as it means it would take IMXI, only 1.97 years of fcf income to pay off all of its debts.
IMXI's Debt to FCF ratio of 1.97 is fine compared to the rest of the industry. IMXI outperforms 76.47% of its industry peers.
IMXI has a Debt/Equity ratio of 1.01. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.01, IMXI perfoms like the industry average, outperforming 43.14% of the companies in the same industry.
Even though the debt/equity ratio score it not favorable for IMXI, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 1.01
Debt/FCF 1.97
Altman-Z 3.58
ROIC/WACC2.76
WACC7.75%
IMXI Yearly LT Debt VS Equity VS FCFIMXI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

IMXI has a Current Ratio of 1.63. This is a normal value and indicates that IMXI is financially healthy and should not expect problems in meeting its short term obligations.
IMXI's Current ratio of 1.63 is fine compared to the rest of the industry. IMXI outperforms 68.63% of its industry peers.
A Quick Ratio of 1.63 indicates that IMXI should not have too much problems paying its short term obligations.
IMXI's Quick ratio of 1.63 is fine compared to the rest of the industry. IMXI outperforms 70.59% of its industry peers.
Industry RankSector Rank
Current Ratio 1.63
Quick Ratio 1.63
IMXI Yearly Current Assets VS Current LiabilitesIMXI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

4

3. Growth

3.1 Past

The earnings per share for IMXI have decreased by -0.49% in the last year.
IMXI shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 26.76% yearly.
The Revenue has decreased by -3.60% in the past year.
The Revenue has been growing by 15.56% on average over the past years. This is quite good.
EPS 1Y (TTM)-0.49%
EPS 3Y21.98%
EPS 5Y26.76%
EPS Q2Q%-7.27%
Revenue 1Y (TTM)-3.6%
Revenue growth 3Y12.78%
Revenue growth 5Y15.56%
Sales Q2Q%-6.06%

3.2 Future

IMXI is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.42% yearly.
Based on estimates for the next years, IMXI will show a small growth in Revenue. The Revenue will grow by 0.46% on average per year.
EPS Next Y-9.23%
EPS Next 2Y0.13%
EPS Next 3Y2.42%
EPS Next 5YN/A
Revenue Next Year-4.2%
Revenue Next 2Y-1.21%
Revenue Next 3Y0.46%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
IMXI Yearly Revenue VS EstimatesIMXI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
IMXI Yearly EPS VS EstimatesIMXI Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

8

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 7.13, the valuation of IMXI can be described as very cheap.
IMXI's Price/Earnings ratio is rather cheap when compared to the industry. IMXI is cheaper than 86.27% of the companies in the same industry.
When comparing the Price/Earnings ratio of IMXI to the average of the S&P500 Index (27.03), we can say IMXI is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 6.72, the valuation of IMXI can be described as very cheap.
Based on the Price/Forward Earnings ratio, IMXI is valued cheaper than 82.35% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.63, IMXI is valued rather cheaply.
Industry RankSector Rank
PE 7.13
Fwd PE 6.72
IMXI Price Earnings VS Forward Price EarningsIMXI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

96.08% of the companies in the same industry are more expensive than IMXI, based on the Enterprise Value to EBITDA ratio.
IMXI's Price/Free Cash Flow ratio is rather cheap when compared to the industry. IMXI is cheaper than 93.14% of the companies in the same industry.
Industry RankSector Rank
P/FCF 5.91
EV/EBITDA 3.75
IMXI Per share dataIMXI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

IMXI has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.27
EPS Next 2Y0.13%
EPS Next 3Y2.42%

0

5. Dividend

5.1 Amount

IMXI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

INTERNATIONAL MONEY EXPRESS

NASDAQ:IMXI (9/5/2025, 10:34:37 AM)

14.55

-0.02 (-0.14%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)08-11 2025-08-11/bmo
Earnings (Next)11-06 2025-11-06/bmo
Inst Owners91.87%
Inst Owner Change-1.46%
Ins Owners4.31%
Ins Owner Change1.45%
Market Cap431.84M
Analysts72.31
Price Target16.32 (12.16%)
Short Float %4.44%
Short Ratio1.69
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-8.66%
Min EPS beat(2)-16.98%
Max EPS beat(2)-0.33%
EPS beat(4)1
Avg EPS beat(4)-5.27%
Min EPS beat(4)-16.98%
Max EPS beat(4)2.89%
EPS beat(8)4
Avg EPS beat(8)-1.83%
EPS beat(12)7
Avg EPS beat(12)0.3%
EPS beat(16)10
Avg EPS beat(16)1.54%
Revenue beat(2)0
Avg Revenue beat(2)-3.99%
Min Revenue beat(2)-4.02%
Max Revenue beat(2)-3.97%
Revenue beat(4)0
Avg Revenue beat(4)-3.77%
Min Revenue beat(4)-4.43%
Max Revenue beat(4)-2.65%
Revenue beat(8)0
Avg Revenue beat(8)-3.35%
Revenue beat(12)0
Avg Revenue beat(12)-3.06%
Revenue beat(16)2
Avg Revenue beat(16)-2.14%
PT rev (1m)6.67%
PT rev (3m)-20%
EPS NQ rev (1m)-1.21%
EPS NQ rev (3m)-15.75%
EPS NY rev (1m)-0.7%
EPS NY rev (3m)-0.47%
Revenue NQ rev (1m)-1.48%
Revenue NQ rev (3m)-6.25%
Revenue NY rev (1m)-1.18%
Revenue NY rev (3m)-1.21%
Valuation
Industry RankSector Rank
PE 7.13
Fwd PE 6.72
P/S 0.67
P/FCF 5.91
P/OCF 4.09
P/B 3.04
P/tB 7.18
EV/EBITDA 3.75
EPS(TTM)2.04
EY14.02%
EPS(NY)2.17
Fwd EY14.89%
FCF(TTM)2.46
FCFY16.91%
OCF(TTM)3.56
OCFY24.45%
SpS21.64
BVpS4.79
TBVpS2.03
PEG (NY)N/A
PEG (5Y)0.27
Profitability
Industry RankSector Rank
ROA 9.93%
ROE 36.17%
ROCE 30.39%
ROIC 21.36%
ROICexc 50.57%
ROICexgc 141.4%
OM 14.32%
PM (TTM) 8.01%
GM N/A
FCFM 11.37%
ROA(3y)11.41%
ROA(5y)12.2%
ROE(3y)40.58%
ROE(5y)38.06%
ROIC(3y)20.03%
ROIC(5y)20.57%
ROICexc(3y)43.96%
ROICexc(5y)44.35%
ROICexgc(3y)95.79%
ROICexgc(5y)98.86%
ROCE(3y)28.49%
ROCE(5y)29.26%
ROICexcg growth 3Y-16.32%
ROICexcg growth 5YN/A
ROICexc growth 3Y-9.68%
ROICexc growth 5Y-2.6%
OM growth 3Y0.47%
OM growth 5Y5.87%
PM growth 3Y-4.31%
PM growth 5Y7.81%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover1.24
Health
Industry RankSector Rank
Debt/Equity 1.01
Debt/FCF 1.97
Debt/EBITDA 1.35
Cap/Depr 215.35%
Cap/Sales 5.07%
Interest Coverage 8.73
Cash Conversion 98.64%
Profit Quality 141.91%
Current Ratio 1.63
Quick Ratio 1.63
Altman-Z 3.58
F-Score7
WACC7.75%
ROIC/WACC2.76
Cap/Depr(3y)181.12%
Cap/Depr(5y)138.87%
Cap/Sales(3y)3.56%
Cap/Sales(5y)2.84%
Profit Quality(3y)80.71%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-0.49%
EPS 3Y21.98%
EPS 5Y26.76%
EPS Q2Q%-7.27%
EPS Next Y-9.23%
EPS Next 2Y0.13%
EPS Next 3Y2.42%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.6%
Revenue growth 3Y12.78%
Revenue growth 5Y15.56%
Sales Q2Q%-6.06%
Revenue Next Year-4.2%
Revenue Next 2Y-1.21%
Revenue Next 3Y0.46%
Revenue Next 5YN/A
EBIT growth 1Y-5.62%
EBIT growth 3Y13.31%
EBIT growth 5Y22.35%
EBIT Next Year8.74%
EBIT Next 3Y4.89%
EBIT Next 5YN/A
FCF growth 1Y13422.8%
FCF growth 3Y-46.37%
FCF growth 5Y-25.68%
OCF growth 1Y894.38%
OCF growth 3Y-12.08%
OCF growth 5Y0.21%